Latest / Santa Reads to You about Medicine

Mon 2026/10/05 Monday Sweep: VESALIUS-CV and Repatha, Triglycerides, Diaper Psoriasis and Retinoblastoma
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
This week's sweep is organized around the comparator — what a treatment was actually tested against, and whether that's the comparison you face in clinic. It leads with VESALIUS-CV, the evolocumab trial in high-risk patients without a prior heart attack or stroke, covering what the twenty-five percent figure means in absolute terms, why "without prior MI or stroke" is not the same as primary prevention, the fact that only one in five patients was on ezetimibe and the 2026 guideline's…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.